BRIDGEWATER, N.J., May 4, 2011 — Axcan Intermediate Holdings Inc. announces that, as of today, it is changing its name to Aptalis Pharma. The rebranding follows the recently completed combination of two specialty pharma companies focused on gastrointestinal diseases: Axcan and Eurand. Aptalis Pharma also has a new corporate logo ...
Media
|
Showing Articles Tagged : Aptalis
|